JPMorgan Chase & Co. Trims Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
JPMorgan Chase & Co. reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 44.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,214,250 shares of the biopharmaceutical company’s stock after selling 5,705,679 shares during the quarter. JPMorgan […]
JPMorgan Chase & Co. reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 44.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,214,250 shares of the biopharmaceutical company’s stock after selling 5,705,679 shares during the quarter. JPMorgan […]
